GoodRx Expands Access to Menopause Hormone Therapies
Today, GoodRx (Nasdaq: GDRX), a leading prescription savings platform, announced its latest initiative aimed at enhancing women's healthcare. The new affordability programs for menopause hormone therapies will broaden access for women who need them. By leveraging the extensive reach of the GoodRx platform, these programs are designed to make crucial medications more affordable and accessible.
The Rising Cost of Menopause Treatments
Recent research highlights a concerning trend: menopause medications have seen an increase in list prices by an astounding 58% since 2014. This uptick in costs places a financial burden on women, who often spend significantly more on healthcare to treat menopause-related symptoms compared to those not experiencing menopause. This gap is sometimes exacerbated by what's known as the “pink tax,” where women face higher medical costs despite receiving the same or fewer services. GoodRx recognizes these inequalities and is determined to address the disparities in coverage and out-of-pocket expenses.
Commitment to Women's Health
“Americans are paying more than ever for medications, and women are disproportionately affected by this trend,” said Dorothy Gemmell, Chief Commercial Officer at GoodRx. She emphasizes that GoodRx is not only striving to make medications affordable but also to empower women from perimenopause through menopause. The focus is on improving the overall quality of life for women, advocating for better treatment options, and shedding light on the complexities of menopause.
New Programs for Hormone Therapies
Eligible patients with valid prescriptions will find low cash prices for brand-name menopause hormone therapies, ranging from $99 to $249, available at over 70,000 pharmacies across the country exclusively through the GoodRx platform. This move aims to ensure women have access to necessary treatments without suffering from financially crippling healthcare costs.
Additional Savings Guides
GoodRx is also providing resources for women searching for cost-effective alternatives for menopause treatments. Their comprehensive Savings Guide for Popular Menopause Treatments will help patients navigate the necessary options to manage their health more affordably.
Support from Health Experts
Dr. Lisa Larkin, Immediate Past President of The Menopause Society, expressed her enthusiasm regarding GoodRx's new initiative. “Menopause is a natural phase of a woman’s life that deserves attention and care, not something to be ignored or stigmatized. By making treatments more accessible, GoodRx is improving health outcomes and enabling women to lead full lives,” she remarked. This sentiment underscores the importance of having conversations about women's health throughout all phases of life.
GoodRx’s Partnerships for Broader Impact
In addition to its efforts concerning menopause treatments, GoodRx collaborates with over 150 brands encompassing pharmaceutical manufacturers and medical device companies. One recent partnership with ARS Pharmaceuticals has resulted in exclusive low-priced access to the medication neffy, showcasing GoodRx's commitment to making medications more attainable. Furthermore, the company has initiated an affordability program with Boehringer Ingelheim for its Humira biosimilar at competitive rates.
Overall, GoodRx now offers cash price options for consumers from more than 50 pharmaceutical brands, expanding access to a wide variety of medications through its dedicated platform.
About GoodRx
GoodRx is the leading prescription savings platform in the United States, trusted by over 25 million consumers and 750,000 healthcare professionals annually. Since 2011, GoodRx has made significant strides in providing access to savings and affordability options for both generic and brand-name medications across a network of over 70,000 pharmacies throughout the country. The platform has helped consumers save over $75 billion on their prescriptions.
Frequently Asked Questions
What are GoodRx's new affordability programs?
GoodRx has launched new affordability programs targeting menopause hormone therapies, aimed at making these essential medications more accessible for women.
How have menopause medication prices changed recently?
Research indicates that menopause medications have increased in list price by 58% since 2014, necessitating initiatives to improve affordability.
Where can patients find these low prices?
Eligible patients can find low cash prices for brand-name menopause hormone therapies at over 70,000 pharmacies across the U.S. exclusively through GoodRx.
Who supports GoodRx's initiative?
Health experts, including Dr. Lisa Larkin of The Menopause Society, support GoodRx's initiatives, emphasizing the need for women's health and access to affordable treatments.
What other partnerships has GoodRx established?
GoodRx collaborates with over 150 brands, including recent partnerships with ARS Pharmaceuticals and Boehringer Ingelheim to provide discounts on various medications.
